Bisphosphonate therapy for children and adolescents with secondary osteoporosis
about
Whole body vibration for preventing and treating osteoporosisBisphosphonates: mechanism of action and role in clinical practiceBisphosphonate therapy in pediatric patientsOsteoporosis in paediatric patients with spina bifidaThe management of osteoporosis in children.Current and emerging treatments for the management of osteogenesis imperfecta.Fractures in myelomeningocele.A practical guide to the monitoring and management of the complications of systemic corticosteroid therapySkeletal health of children and adolescents with inflammatory bowel disease.Endocrine disorders in Fanconi anemia: recommendations for screening and treatment.Approach to the child with fractures.Diagnosing and treating Diamond Blackfan anaemia: results of an international clinical consensus conference.Safety & Efficacy of Cyclic Zoledronic Acid Therapy on Pediatric Secondary Osteoporosis.Osteoporosis in children: pediatric and pediatric rheumatology perspective: a review.Effect of bisphosphonates on the rapidly growing male murine skeleton.The use of bisphosphonates in children: review of the literature and guidelines for dental management.Underweight, overweight, and pediatric bone fragility: impact and management.Interventions to prevent and treat corticosteroid-induced osteoporosis and prevent osteoporotic fractures in Duchenne muscular dystrophy.Osteoporosis in Children with Chronic Illnesses: Diagnosis, Monitoring, and Treatment.Efficacy of pamidronate in pediatric osteosarcoma patients with low bone mineral density.Lower incidence of fracture after IV bisphosphonates in girls with Rett syndrome and severe bone fragility.Effects of Bisphosphonate Administration on Cleft Bone Graft in a Rat Model.PTH(1-34) and zoledronic acid have differing longitudinal effects on juvenile mouse femur strength and morphology.Impaired Bone Mineral Density in Pediatric Patients with Chronic Graft-versus-Host Disease.Beyond the definitions of the phenotypic complications of sickle cell disease: an update on management.
P2860
Q24239866-EF776683-C30F-4E89-B18B-954D27928D92Q24644708-0CBB3341-A071-4903-8F67-63160787FACAQ26830702-903A4E22-B27F-4F8A-AB7B-4E2D7B44A768Q26996355-4C2940EA-0C41-4395-B8FD-CEC96EDA6080Q30251490-298EA67D-CD5A-42D8-B1CD-CFE7DE84BF41Q34133308-5FFC395D-218B-4F07-9768-4EF0FA88E476Q34166648-C7CD48C5-6549-44B0-9D90-F44842986B83Q34364143-395EB9A6-B1A0-4555-A5E1-1355E347308EQ35065044-75BA01A3-BB43-4C22-BFAB-2659A66E0C98Q35096884-4DCFD740-4CD9-49DD-850F-FFFD2B23CF65Q35101807-4608914C-72B0-4430-9FC1-0CF67DDD3F92Q37125399-69A96A2B-09E7-4057-A307-2013137604A6Q37242697-C8D8D9ED-DA1F-4EBF-B559-2B8B5240758EQ37402046-0C243134-9F86-4379-A915-1F12BB0B3F93Q37648066-A448BD07-8BE4-4FA6-89B4-36EB33627AA0Q38185138-E5D701FB-4CED-4F93-8F90-91C79572BBF2Q38225482-097AABAC-CE1B-466E-AB4F-22F5880D8143Q38766431-8D041709-F941-4589-9C59-2AC7C0FB270CQ39377609-3968ABB2-79F6-40D6-B52F-FFC1DFA0B55DQ40309785-41A39C1D-FFA7-4D7C-96BB-004367300D1DQ43007739-7C8011B5-AC96-4ED9-97FB-333E660E82B4Q47888617-0A5A2A9A-1810-43BD-A2BD-AB80CC456E48Q51800119-FF91CB9D-8776-42DB-B5BA-4538D1C49E6CQ52729477-A489BADC-4FFD-4EA8-BE99-DBB775CA06C1Q55427971-0DFB89BB-6051-44C0-84BE-5AF4C7AA2C39
P2860
Bisphosphonate therapy for children and adolescents with secondary osteoporosis
description
2007 nî lūn-bûn
@nan
2007 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Bisphosphonate therapy for children and adolescents with secondary osteoporosis
@ast
Bisphosphonate therapy for children and adolescents with secondary osteoporosis
@en
Bisphosphonate therapy for children and adolescents with secondary osteoporosis
@en-gb
Bisphosphonate therapy for children and adolescents with secondary osteoporosis
@nl
type
label
Bisphosphonate therapy for children and adolescents with secondary osteoporosis
@ast
Bisphosphonate therapy for children and adolescents with secondary osteoporosis
@en
Bisphosphonate therapy for children and adolescents with secondary osteoporosis
@en-gb
Bisphosphonate therapy for children and adolescents with secondary osteoporosis
@nl
prefLabel
Bisphosphonate therapy for children and adolescents with secondary osteoporosis
@ast
Bisphosphonate therapy for children and adolescents with secondary osteoporosis
@en
Bisphosphonate therapy for children and adolescents with secondary osteoporosis
@en-gb
Bisphosphonate therapy for children and adolescents with secondary osteoporosis
@nl
P2093
P2860
P50
P3181
P1476
Bisphosphonate therapy for children and adolescents with secondary osteoporosis
@en
P2093
Andrea Tricco
Ann Cranney
Isabelle Gaboury
Leanne Ward
Nick Barrowman
Phuc-Nhi Phuong
P2860
P3181
P356
10.1002/14651858.CD005324.PUB2
P577
2007-10-17T00:00:00Z